Navigation Links
Cardium Announces Market Introduction of New Alena™ Clinical Strength Carb Blocker to Expand the MedPodium Healthy Lifestyle Product Line
Date:7/12/2011

use in MedPodium's easy-to-swallow pharmaceutical grade capsules.  Alena temporarily inhibits the alpha-amylase enzyme from digesting complex carbohydrates commonly found in modern diets, thus slowing their absorption and reducing their caloric impact*.  Alena works selectively to reduce the uptake of the types of carbohydrates found in many starchy foods, without blocking the absorption of "good" simple carbohydrates such as those derived from vegetables and whole grains*.  A scientific dossier of the Phase 2® clinical studies can be accessed at http://www.phase2info.com/pdf/phase2-product-overview.pdf.

"The addition of our new Alena™ dietary supplement represents another step toward broadening the Company's MedPodium Nutra-Apps healthy lifestyles brand platform and product portfolio for the influential millennial consumer base as well as other modern consumers," stated Christopher J. Reinhard, Cardium's Chairman and Chief Executive Officer.  "Our Alena™ carbohydrate blocker can be used as part of a formal diet and exercise plan, or whenever temptation leads to consumption of junk food snacks or fast food meals, in order to help manage caloric intake from starchy foods.  Also, like our other products, our concentrated clinical strength Alena™ formulation allows for small easy-to-swallow, pharmaceutically-sealed and tasteless capsules.  Alena™ has been custom formulated to offer the highest Phase 2 dosage with the smallest capsule size."

Reinhard added, "We plan to continue to identify and evaluate new or improved nutritional ingredients and formulations from around the world for our MedPodium healthy lifestyle brand platform.  MedPodium's goal is to offer a portfolio of pharmaceutical grade and easy-to-use products containing best-in-class key ingredients that address the unique health needs of today's technology-dri
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cardium Announces Plans to Acquire Transdel Pharmaceuticals Phase 3 Topical Analgesic and Cosmeceutical Business Assets
2. Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation
3. Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones
4. Cardium to Present at OneMedForum San Francisco 2011 Conference
5. Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process
6. Cardium Reports on Fourth Quarter and Year-End 2009 Financial Results and Recent Developments
7. Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development
8. Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds
9. Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers
10. Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study
11. Cardium Announces Completion of Patient Recruitment in Phase 2b Clinical Trial of Excellarate(TM) for the Potential Treatment of Diabetic Foot Ulcers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: ... participate in the Deutsche Bank Health Care Conference to ... Hotel.  Mr. Adrian Adams , Chief ... overview of the Company and its product pipeline at ... (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The ...
(Date:5/24/2013)... May 24, 2013 The potential ... systemic delivery of therapeutic agents has been receiving undeniable ... delivery showing significant promise. The crucial formulation considerations for ... device play a major role in the efficiency of ... the development of new formulation techniques and devices in ...
(Date:5/23/2013)...  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ) ... Life Science Firm of the Year by the Tech Council ... at the TCM,s 25 th Annual Tech Awards Celebration ... Awards Celebration recognizes the leaders and innovators in the technology ... and the surrounding regions. "We are deeply ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2
... 2011 With the support of Key Opinion Leaders ... the time and attention of KOLs is intensifying. But ... landscape for creating and maintaining KOL and physician relationships. ... KOL landscape, Best Practices, LLC has published an updated ...
... Endo Pharmaceuticals (Nasdaq: ENDP ) announced today ... of President, HealthTronics Inc., effective Aug. 29, 2011. HealthTronics, ... urological products and services based in Austin, Texas. ... HealthTronics Group President James Whittenburg, who is staying through ...
Cached Medicine Technology:Pharma Medical Science Liaison Outreach Shifting Away from Traditional Company Sales Regions 2Endo Pharmaceuticals Announces Leadership Change at HealthTronics Subsidiary: Appoints Kelly Huang, Ph.D. New President 2Endo Pharmaceuticals Announces Leadership Change at HealthTronics Subsidiary: Appoints Kelly Huang, Ph.D. New President 3
(Date:5/25/2013)... New York, NY (PRWEB) May 25, 2013 Country ... was Jason Aldean's opening act in 2012. Due to overwhelming ... countless venues during 2013. , Luke Bryan has written ... a songwriter nearly a decade ago back in the mid-2000 era. ... Billy Currington and Travis Tritt. , When Luke was 14, ...
(Date:5/25/2013)... 25, 2013 According to an article in ... a Feeling,” nearly 30 million Americans tan indoors each year ... despite knowing the health risks. New research suggests ... addictive effect on the brains of some tanners (Go to ... article so I can’t say that I fully support this ...
(Date:5/25/2013)... It's not astonishing that holidays are amongst the most ... from family, friends and co-workers. Between the parties to ... their parents can afford, parties to arrange, and so ... anniversaries and it seems like an eternal cycle of ... and income can’t catch up to the expenses of ...
(Date:5/25/2013)... May 25, 2013 Life science and ... used to detect and create a new substance with ... and are also known as biotechnology reagents. Such reagents ... and education. , This market is driven by factors ... the field of therapeutics, growth in research and rapid ...
(Date:5/25/2013)... New York, New York (PRWEB) May 25, 2013 ... a federal multidistrict litigation underway in U.S. District Court, ... Liebhard LLP reports. According to a Case Management ... procedures that govern the filing of contested motions in ... for filing those motions. (In re: Actos Product Liability ...
Breaking Medicine News(10 mins):Health News:Luke Bryan Tickets: Prices Slashed on Luke Bryan Tickets in Raleigh, Bethel, Camden, Peoria, Nashville, Hartford, Chicago, Boston, Atlanta, Indianapolis & SaratogaSprings 2Health News:Sun Damage – Are UV Rays Addictive? 2Health News:TheBeautyPlace.com Debuts Their Brand New Beauty Kits 2Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 2Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 3Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 3
... 17 Carla Bluhm, a developmental psychologist and visiting assistant ... class of 2007, have recently completed a book on the ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20080220/DC14623 ) , ... Identity and the New Science of Face Transplants" begins with ...
... for Physicians , , VOORHEES, ... infection (CDI) in geriatric and pediatric populations ... in CDI incidence in many age groups, healthcare professionals need ... patient populations. , , To ...
... Dec. 17 minSURG Corporation, along with,its ... NuFix,Inc. ("NuFix"), along with its affiliate Nutech ... settlement of the lawsuits styled Orthopedic,Development Corporation ... Inc., Kenneth Horton and Todd Gilbert, Case ...
... 17 Michelle Aguilar may be the latest,"Biggest Loser" but she ... that when working out hard, it,s important to include the nutrients ... a day provide.,Aguilar is the latest person to lend her upper ... (Photo: http://www.newscom.com/cgi-bin/prnh/20081217/AQW560 ) , ...
... Labs announces the,availability of its advanced ocular nutrition line ... CVS Pharmacy stores ( www.cvs.com ),nationwide. , ... (Photo: http://www.newscom.com/cgi-bin/prnh/20081217/CLW029-b ... marks the first time EyeScience Macular Health Formula(TM) and,EyeScience ...
... improve cognitive impairment, study says , , WEDNESDAY, Dec. ... Alzheimer,s patients, cognitive symptoms are also a safe ... such as aggression, wandering and paranoia, according to ... that examined the effectiveness of three popular cholinesterase ...
Cached Medicine News:Health News:Psychology of Face Transplants is Subject of New Book by Allegheny College Professor 2Health News:Current Concepts in Clostridium difficile Infection: A Focus on Geriatric and Pediatric Patients 2Health News:EyeScience's New Ocular Nutrition Supplements Available at CVS Stores 2Health News:Alzheimer's Drugs Also Treat Behavioral, Psych Problems 2
... a whole blood control for evaluating the ... measure automated blood cell counts in patient ... RBC and WBC values for the Abbott ... LH750/LH 755 (levels 2 and 3 only) ...
iSleep 20i is an advanced high performance CPAP with outstanding self-adjusting i‑technology....
Spectrum Dynamics empowers Nuclear Imaging with the SmartR Technology,of the D-SPECT Cardiac Imaging System. The D-SPECT is powered by BroadView Technology to provide unprecedented throughput, whil...
Diagnosoft HARP is designed for rapid analysis of tagged cardiac MR images using the HARP technology, which is packaged into an intuitive, easy-to-use graphic user interface....
Medicine Products: